Drew Austin welcomes two experts in the Biotech field to discuss discoveries in psychedelics, cancer treatment, and more. Peter Weijmarshausen, CEO/Co-founder of Humane Genomics and Sam Clark, Founder/CEO of Terran Biosciences highlight how biotech is offering amazing opportunities for investments in scientific innovation. Participating Panelists:- Drew Austin, Managing Partner, Red Beard Ventures- Peter Weijmarshausen, CEO/Co-founder, Humane Genomics- Sam Clark, Founder/CEO, Terran BiosciencesMain Topics:- Terran Bioscience developing prescription psychedelic therapies for mental health.- Human Genomics' revolutionary approach to using synthetic biology to target and eliminate cancer cells.- The challenges of scientific innovation.- Finding opportunities for capital deployment in biotech- Developing affordable treatments for all - making healthcare accessibleRed Beard Ventures: https://redbeard.ventures/Angel List Syndicate: https://venture.angellist.com/red-beard-ventures-drew-austin/syndicate?utm_campaign=syndicate_direct_linkRed Beard Radio is Sponsored by Alto. Alto makes it easy for individuals to invest in alternative assets with their retirement funds through a self-directed IRA. Access private deals on Alto Marketplace, their new platform for accredited investors: https://www.altoira.com/marketplaceX: @RedBeardVCWatch the show on YouTube: https://www.youtube.com/channel/UCY-DGmpg2v2rEcXEjn8hJlw

Ver todos los episodios